We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Heska Corporation | NASDAQ:HSKA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 119.99 | 109.74 | 130.24 | 0 | 01:00:00 |
LOVELAND, Colo., April 21, 2023 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty solutions, announces its 2023 Annual Meeting of Stockholders. The virtual event is scheduled for 9 a.m. MT / 11 a.m. ET on Wednesday, May 3, 2023. Stockholders of record as of March 6, 2023, are entitled to notice of, participate in and vote at, the annual meeting. All stockholders are encouraged to vote on the proposed matters before the Annual Meeting by proxy as described in the Company's proxy materials provided to stockholders.
2023 Annual Meeting of Stockholders
Wednesday, May 3, 2023
9 a.m. MT / 11 a.m. ET
To access the webcast, please visit: http://meetnow.global/M2CPXHH.
Heska Corporation (NASDAQ: HSKA) sells, manufactures, markets, and supports diagnostic and specialty products and solutions for veterinary practitioners. Heska's portfolio includes point-of-care diagnostic laboratory instruments and consumables including rapid assay diagnostic products; digital cytology services; point-of-care digital imaging diagnostic products; local and cloud-based data services; practice information management software ("PIMS") and related software and support; reference laboratory testing; allergy testing and immunotherapy; heartworm preventive products; and vaccines. Heska's primary focus is supporting companion animal veterinarians in providing care to their patients. Heska's business is composed of two operating and reportable segments: North America and International. North America consists of the United States, Canada and Mexico. International consists of geographies outside of North America, primarily in Germany, Italy, Spain, France, Switzerland, Australia and Malaysia. The Company's strategic focus on point-of-care diagnostic laboratory and imaging products is included in both segments. The North America segment also includes the contract manufacturing of vaccines and pharmaceutical products and a small veterinary laboratory, and the International segment includes PIMS business and veterinary laboratories. For more information, please visit www.heska.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/heska-announces-annual-meeting-of-stockholders-on-may-3-2023-301803755.html
SOURCE Heska Corporation
Copyright 2023 PR Newswire
1 Year Heska Chart |
1 Month Heska Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions